{"DataElement":{"publicId":"3204424","version":"1","preferredName":"Chronic Lymphocytic Leukemia Rai Stage","preferredDefinition":"Information related to the Rai stage for chronic lymphocytic leukemia.","longName":"2189808v1.0:3204418v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2189808","version":"1","preferredName":"CLL Leukemia Rai Description","preferredDefinition":"information related to the Rai stage or description for chronic lymphocytic leukemia.","longName":"CLL_LEUK_RAI_DESC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206660","version":"1","preferredName":"CLL Leukemia","preferredDefinition":"The most common type of chronic lymphoid leukemia, and comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  The clinical course is indolent, but this type of leukemia is not considered to be curable with available therapy. (WHO, 2001) -- 2003:A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years. -- 2004","longName":"C3163:C3161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Lymphocytic Leukemia","conceptCode":"C3163","definition":"The most common type of chronic lymphoid leukemia.  It comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  This type of leukemia is not considered to be curable with available therapy. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FEFE-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2660713","version":"1","preferredName":"Rai Staging System Description ","preferredDefinition":"A staging system for Chronic Lymphocytic Leukemia.  Stage 0: absolute lymphocytosis (>15,000 per cubic millimeter) without adenopathy, hepatosplenomegaly, anemia, or thrombocytopenia; Stage I: absolute lymphocytosis with lymphadenopathy without hepatosple:Description; a statement that represents something in words.","longName":"C20115:C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rai Staging System","conceptCode":"C20115","definition":"A staging system for Chronic Lymphocytic Leukemia.  Stage 0: absolute lymphocytosis (>15,000 per cubic millimeter) without adenopathy, hepatosplenomegaly, anemia, or thrombocytopenia; Stage I: absolute lymphocytosis with lymphadenopathy without hepatosplenomegaly, anemia, or thrombocytopenia; Stage II: absolute lymphocytosis with either hepatomegaly or splenomegaly, with or without lymphadenopathy; Stage III: absolute lymphocytosis and anemia (hemoglobin <11 g/dL) with or without lymphadenopathy, hepatomegaly, or splenomegaly; Stage IV: absolute lymphocytosis and thrombocytopenia (<100,000 per cubic millimeter) with or without lymphadenopathy, hepatomegaly, splenomegaly, or anemia.  (from OncoLink)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33E73C82-CB3A-5882-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-27","modifiedBy":"ONEDATA","dateModified":"2007-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6406F92-0805-4359-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3204418","version":"1","preferredName":"Chronic Lymphocytic Leukemia Rai Staging System Stage","preferredDefinition":"The RAI stage for a chronic lymphocytic leukemia.","longName":"3204418v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Complete remission","valueDescription":"Complete Remission","ValueMeaning":{"publicId":"2577915","version":"1","preferredName":"Complete Remission","longName":"2577915","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD68-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-24","modifiedBy":"ONEDATA","dateModified":"2006-02-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B20386B0-DB29-9FF5-E040-BB89AD4355C5","beginDate":"2011-11-18","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-11-18","modifiedBy":"ONEDATA","dateModified":"2011-11-18","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9EAD32E1-5D39-52BE-E040-BB89AD437374","beginDate":"2011-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-03-17","modifiedBy":"ONEDATA","dateModified":"2011-03-17","deletedIndicator":"No"},{"value":"Stage II","valueDescription":"Stage II","ValueMeaning":{"publicId":"3204421","version":"1","preferredName":"Stage II","longName":"3204421","preferredDefinition":"Lymphocytosis plus enlarged liver or spleen with or without lymphadenopathy.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9EAD32E1-5D87-52BE-E040-BB89AD437374","latestVersionIndicator":"Yes","beginDate":"2011-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-03-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9EAD32E1-5D9F-52BE-E040-BB89AD437374","beginDate":"2011-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-03-17","modifiedBy":"ONEDATA","dateModified":"2011-03-17","deletedIndicator":"No"},{"value":"Stage I","valueDescription":"Stage I","ValueMeaning":{"publicId":"3624198","version":"1","preferredName":"Stage I","longName":"3624198","preferredDefinition":"Lymphocytosis plus enlarged lymph nodes (lymphadenopathy).","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD49D59E-7E4C-3D04-E040-BB89AD4346D9","latestVersionIndicator":"Yes","beginDate":"2012-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-10-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD49D59E-7E64-3D04-E040-BB89AD4346D9","beginDate":"2011-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-10-30","modifiedBy":"ONEDATA","dateModified":"2012-10-30","deletedIndicator":"No"},{"value":"Stage 0","valueDescription":"Stage 0","ValueMeaning":{"publicId":"3628869","version":"1","preferredName":"Stage 0","longName":"3628869","preferredDefinition":"Lymphocytosis (greater than 15,000 x 10E9/L) in blood or bone marrow only.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEF0811C-0150-4964-E040-BB89AD436301","latestVersionIndicator":"Yes","beginDate":"2012-11-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-11-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEF0811C-0168-4964-E040-BB89AD436301","beginDate":"2011-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-11-20","modifiedBy":"ONEDATA","dateModified":"2012-11-20","deletedIndicator":"No"},{"value":"Stage III","valueDescription":"Stage III","ValueMeaning":{"publicId":"3628870","version":"1","preferredName":"Stage III","longName":"3628870","preferredDefinition":"Lymphocytosis plus anemia (Hgb less than 11 g/dL) with or without enlarged liver, spleen, or lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEF0811C-0172-4964-E040-BB89AD436301","latestVersionIndicator":"Yes","beginDate":"2012-11-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-11-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEF0811C-018A-4964-E040-BB89AD436301","beginDate":"2011-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-11-20","modifiedBy":"ONEDATA","dateModified":"2012-11-20","deletedIndicator":"No"},{"value":"Stage IV","valueDescription":"Stage IV","ValueMeaning":{"publicId":"3628871","version":"1","preferredName":"Stage IV","longName":"3628871","preferredDefinition":"Lymphocytosis plus thrombocytopenia (platelet count less than 100 x 10E9/L) with or without anemia or\r\nenlarged liver, spleen, or lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEF0811C-0194-4964-E040-BB89AD436301","latestVersionIndicator":"Yes","beginDate":"2012-11-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-11-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEF0811C-01AC-4964-E040-BB89AD436301","beginDate":"2011-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-11-20","modifiedBy":"ONEDATA","dateModified":"2012-11-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3292737","version":"1","preferredName":"Chronic Lymphocytic Leukemia Rai Staging System Stage","preferredDefinition":"The most common type of chronic lymphoid leukemia. It comprises 90% of chronic lymphoid leukemias in the United States. Morphologically, the neoplastic cells are small, round B-lymphocytes. This type of leukemia is not considered to be curable with available therapy. (WHO, 2001):A staging system for Chronic Lymphocytic Leukemia.  Stage 0: absolute lymphocytosis (>15,000 per cubic millimeter) without adenopathy, hepatosplenomegaly, anemia, or thrombocytopenia; Stage I: absolute lymphocytosis with lymphadenopathy without hepatosple:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C3163:C20115:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Lymphocytic Leukemia","conceptCode":"C3163","definition":"The most common type of chronic lymphoid leukemia.  It comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  This type of leukemia is not considered to be curable with available therapy. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Rai Staging System","conceptCode":"C20115","definition":"A staging system for Chronic Lymphocytic Leukemia.  Stage 0: absolute lymphocytosis (>15,000 per cubic millimeter) without adenopathy, hepatosplenomegaly, anemia, or thrombocytopenia; Stage I: absolute lymphocytosis with lymphadenopathy without hepatosplenomegaly, anemia, or thrombocytopenia; Stage II: absolute lymphocytosis with either hepatomegaly or splenomegaly, with or without lymphadenopathy; Stage III: absolute lymphocytosis and anemia (hemoglobin <11 g/dL) with or without lymphadenopathy, hepatomegaly, or splenomegaly; Stage IV: absolute lymphocytosis and thrombocytopenia (<100,000 per cubic millimeter) with or without lymphadenopathy, hepatomegaly, splenomegaly, or anemia.  (from OncoLink)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEB5982B-FC9D-DDB1-E040-BB89AD435B98","latestVersionIndicator":"Yes","beginDate":"2011-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-10-07","modifiedBy":"ONEDATA","dateModified":"2011-10-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9EAD32E1-5D22-52BE-E040-BB89AD437374","latestVersionIndicator":"Yes","beginDate":"2011-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-03-17","modifiedBy":"KUMMEROA","dateModified":"2020-12-16","changeDescription":". 2020-12-16 ak OK to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"3279271","version":"1","longName":"Disease Status","context":"NHLBI"},{"publicId":"2964930","version":"1","longName":"2013r1: CLL Pre-HSCT Data","context":"NHLBI"}]}],"AlternateNames":[{"name":"cll_base_prep_rai_stage","type":"NMDP_FN","context":"NHLBI"},{"name":"cll_base_diag_rai_stage","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the Rai stage for ch","type":"Preferred Question Text","description":"What was the Rai stage for chronic lymphocytic leukemia?","url":null,"context":"NHLBI"},{"name":"What was the Rai stage?","type":"Alternate Question Text","description":"What was the Rai stage?","url":null,"context":"NHLBI"},{"name":"Specify the chronic lymphocytic leukemia Rai stage:","type":"Alternate Question Text","description":"Specify the chronic lymphocytic leukemia Rai stage:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9EAD2E86-24E0-AAC1-E040-BB89AD43794B","latestVersionIndicator":"Yes","beginDate":"2011-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-03-17","modifiedBy":"KUMMEROA","dateModified":"2020-12-16","changeDescription":". 2020-12-16 ak OK to release per WZ. System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}